This review highlights the role of matrix metalloproteinases in the pathogenesis of preeclampsia and their potential as therapeutic targets.
No takes yet. Share an insight, caveat, or question.
Matrix metalloproteinases may inform preeclampsia therapies; leaves open clinical translation pending prospective trials.
Palei et al. (2013) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: